logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
N

Naoki Kashihara

department of nephrology and hypertension

55H指数
511论文数
1.3W被引数
收录论文 101
发表时间
logo
Atherosclerosis prediction with large language models via prompt engineering通过提示工程利用大型语言模型进行动脉粥样硬化预测
errJournal of Human Hypertension
IF3.4
err2026-09-07
err0
PREAI
errHibiki Murase; Kei Hiroshima; Kento Uchida; Mizuki Ohashi; Hiroyuki Daida; Naoki Kashihara; Naoki Nakashima; Anthony J. Viera; Kentaro Fujishiro; Hyeon Chang Kim; Shinichi Shirakawa; Yuichiro Yano
err分享
err收藏
Iptacopan in patients with IgA nephropathy from East AsiaIptacopan在东亚IgA肾病患者的应用
errKidney International Reports
IF5.7
err2025-11-07
err0
errOAAI
errHong Zhang; Vlado Perkovic; Jonathan Barratt; Dana V. Rizk; Brad Rovin; Hernán Trimarchi; Bart Maes; Tobias Merkel; Manasi Desai; Soudeh Ansari; Ronny Renfurm; Thomas Hach; Naoki Kashihara
err分享
err收藏
The non-steroidal mineralocorticoid receptor blocker esaxerenone reduces glomerular hyperfiltration and albuminuria非甾体类盐皮质激素受体阻滞剂依 saxerenone 可降低肾小球高滤过和蛋白尿
errNephrology Dialysis Transplantation
IF5.6
err2025-11-06
err0
errOAAI
errRie Tatsugawa; Kengo Kidokoro; Tsukasa Iwakura; Akira Hirano; Eriko Kajimoto; Masanobu Takasu; Masafumi Wada; Hiroshi Kitao; Yoshihisa Wada; Georgina Gyarmati; Seiji Kishi; Hajime Nagasu; David Z I Cherney; Janos Peti-peterdi; Tamaki Sasaki; Naoki Kashihara
err分享
err收藏
Proteinuria reduction as a surrogate endpoint for clinical study of IgA nephropathy in Japanese patients: data from the J-CKD-DB-Ex日本患者IgA肾病临床研究中以蛋白尿减少作为替代终点的数据：来自J-CKD-DB-Ex
errCLINICAL AND EXPERIMENTAL NEPHROLOGY
IF1.7
err2025-11-01
err0
errOAAI
errKashihara, Naoki; Itano, Seiji; Nakashima, Takaya; Goto, Tadahiro; Yoshihara, Keisuke; Eguchi, Shunsuke; Iekushi, Kazuma; Isaka, Yoshitaka; Nagasu, Hajime
err分享
err收藏
Effect of iptacopan discontinuation on proteinuria and complement biomarkers in patients with immunoglobulin A nephropathy (IgAN): a post hoc analysis from a Phase II trialiptacopan停用对免疫球蛋白A肾病（IgAN）患者蛋白尿和补体生物标志物的影响：一项来自II期试验的事后分析
errNephrology Dialysis Transplantation
IF5.6
err2025-10-01
err0
errOAAI
errBarratt, Jonathan; Rizk, Dana; Zhang, Hong; Maes, Bart; Kashihara, Naoki; Rovin, Brad; Trimarchi, Hernan; Kollins, Dmitrij; Desai, Manasi; Papachristofi, Olympia; Koukouli, Evanthia; Perkovic, Vlado
err分享
err收藏
Characteristics and cardio-renal outcomes in patients with CKD receiving guideline-directed medical therapy: insights from DISCOVER CKD接受指南指导性药物治疗的患者中CKD的特征及心肾结局：来自DISCOVER CKD的见解
errNephrology Dialysis Transplantation
IF5.6
err2025-10-01
err0
errOAAI
errPecoits-Filho, Roberto; Kanda, Eiichiro; Kashihara, Naoki; Ofori-Asenso, Richard; Chen, Hungta; Pentakota, Surendra; Jarbrink, Krister; Garcia Sanchez, Juan Jose; Lam, Carolyn S. P.; Fishbane, Steven; Pollock, Carol
err分享
err收藏
Outcomes in New User Cohorts of SGLT2 Inhibitors or GLP-1 Receptor Agonists with Type 2 Diabetes and Chronic Kidney Disease新用户队列中，2型糖尿病合并慢性肾脏病患者使用SGLT2抑制剂或GLP-1受体激动剂的结局。
errDiabetes Therapy
IF2.6
err2025-06-04
err0
errOAAI
errJ. Bradley Layton; Ryan Ziemiecki; Catherine B. Johannes; Manel Pladevall-Vila; Anam M. Khan; Natalie Ebert; Csaba P. Kovesdy; Christian Fynbo Christiansen; Aníbal García-Sempere; Hiroshi Kanegae; Craig I. Coleman; Michael Walsh; Ina Trolle Andersen; Clara Rodríguez-Bernal; Celia Robles Cabaniñas; Reimar W. Thomsen; Alfredo E. Farjat; Alain Gay; Patrick Gee; Isabel Hurtado; Naoki Kashihara; Philip Vestergaard Munch; Fangfang Liu; Suguru Okami; Satoshi Yamashita; Yuichiro Yano; David Vizcaya; Nikolaus G. Oberprieler
err分享
err收藏
Baseline Characteristics of the DISCOVER CKD Prospective Cohort (Nov, 10.1007/s12325-024-03028-z, 2024)
errADVANCES IN THERAPY
IF4
err2025-02-03
err0
errOAAI
errPollock, Carol; Carrero, Juan-Jesus; Kanda, Eiichiro; Ofori-Asenso, Richard; Chen, Hungta; Garcia Sanchez, Juan Jose; Pentakota, Surendra; Pecoits-Filho, Roberto; Fishbane, Steven; Lam, Carolyn S. P.; Kashihara, Naoki; Wheeler, David C.
err分享
err收藏
Oral microbiome alpha diversity and all-cause, cardiovascular, and non-cardiovascular mortality in US adults: Evidence from the NHANES 2009-2019
errATHEROSCLEROSIS
IF5.7
err2025-02-01
err0
PREAI
errMondal, Rajib; Ritu, Rani Baroi; Kitaoka, Kaori; Azahar, Nazar Mohd; Moniruzzaman, Mohammad; Ogata, Soshiro; Kiyoshige, Eri; Tohara, Haruka; Kobayashi, Yusuke; Kashihara, Naoki; Naito, Toshio; Nakashima, Naoki; Tamura, Kosuke; Nishimura, Kunihiro; Viera, Anthony J.; Yano, Yuichiro
err分享
err收藏
The Role of Mitochondria in Diabetic Kidney Disease and Potential Therapeutic Targets
errKIDNEY INTERNATIONAL REPORTS
IF5.7
err2025-02-01
err0
errOAAI
errTakasu, Masanobu; Kishi, Seiji; Nagasu, Hajime; Kidokoro, Kengo; Brooks, Craig R.; Kashihara, Naoki
err分享
err收藏
Baseline Characteristics of the DISCOVER CKD Prospective Cohort
errADVANCES IN THERAPY
IF4
err2024-11-29
err1
PREAI
errPollock, Carol; Carrero, Juan-Jesus; Kanda, Eiichiro; Ofori-Asenso, Richard; Chen, Hungta; Sanchez, Juan Jose Garcia; Pentakota, Surendra; Pecoits-Filho, Roberto; Fishbane, Steven; Lam, Carolyn S. P.; Kashihara, Naoki; Wheeler, David C.
err分享
err收藏
The health-economic impact of urine albumin-to-creatinine ratio testing for chronic kidney disease in Japanese patients with type 2 diabetes
errJOURNAL OF DIABETES INVESTIGATION
IF3
err2024-11-22
err0
PREAI
errAsahi, Koichi; Konta, Tsuneo; Tamura, Kouichi; Tanaka, Fumitaka; Fukui, Akira; Nakamura, Yusuke; Hirose, Junichi; Ohara, Kenichi; Shijoh, Yoko; Carter, Matthew; Meredith, Kimberley; Harris, James; Akerborg, Orjan; Kashihara, Naoki; Yokoo, Takashi
err分享
err收藏
Association between proteinuria and mineral metabolism disorders in chronic kidney disease: the Japan chronic kidney disease database extension (J-CKD-DB-Ex)
errSCIENTIFIC REPORTS
IF3.9
err2024-11-11
err0
errOAAI
errShimamoto, Sho; Nakahara, Takako; Yamada, Shunsuke; Nagasu, Hajime; Kishi, Seiji; Nakashima, Naoki; Tsuruya, Kazuhiko; Okada, Hirokazu; Tamura, Kouichi; Narita, Ichiei; Maruyama, Shoichi; Yano, Yuichiro; Yokoo, Takashi; Wada, Takashi; Wada, Jun; Kanda, Eiichiro; Kataoka, Hiromi; Nangaku, Masaomi; Kashihara, Naoki; Nakano, Toshiaki
err分享
err收藏
ASK-1 activation exacerbates kidney dysfunction via increment of glomerular permeability and accelerates cellular aging in diabetic kidney disease model mice
errSCIENTIFIC REPORTS
IF3.9
err2024-11-02
err0
errOAAI
errKajimoto, Eriko; Nagasu, Hajime; Takasu, Masanobu; Kishi, Seiji; Wada, Masafumi; Tatsugawa, Rie; Hirano, Akira; Iwakura, Tsukasa; Umeno, Reina; Wada, Yoshihisa; Itano, Seiji; Kadoya, Hiroyuki; Kidokoro, Kengo; Sasaki, Tamaki; Kashihara, Naoki
err分享
err收藏
Evaluation of glomerular hemodynamic changes by sodium-glucose-transporter 2 inhibition in type 2 diabetic rats using in vivo imaging see commentary
errKIDNEY INTERNATIONAL
IF12.6
err2024-09-01
err2
errOAAI
errWada, Yoshihisa; Kidokoro, Kengo; Kondo, Megumi; Tokuyama, Atsuyuki; Kadoya, Hiroyuki; Nagasu, Hajime; Kanda, Eiichiro; Sasaki, Tamaki; Cherney, David Z. I.; Kashihara, Naoki
err分享
err收藏
The Lived Experience of Patients with Chronic Kidney Disease: Insights From DISCOVER CKD
errAMERICAN JOURNAL OF NEPHROLOGY
IF3.2
err2024-08-22
err0
errOAAI
errPollock, Carol; Carrero, Juan-Jesus; Kanda, Eiichiro; Ofori-Asenso, Richard; Palmer, Ewelina; Niklasson, Anna; Linder, Andrew; Woodward, Helen; Pentakota, Surendra; Garcia Sanchez, Juan Jose; Kashihara, Naoki; Fishbane, Steven; Pecoits-Filho, Roberto; Wheeler, David C.
err分享
err收藏
Gross Hematuria after the COVID-19 mRNA Vaccination: Nationwide Multicenter Prospective Cohort Study in Japan
errKIDNEY360
IF3
err2024-07-08
err3
errOAAI
errAoki, Ryousuke; Nihei, Yoshihito; Matsuzaki, Keiichi; Suzuki, Hitoshi; Kihara, Masao; Ogawa, Asa; Nishino, Tomoya; Sanada, Satoru; Yokote, Shinya; Okabe, Masahiro; Shirai, Sayuri; Fukuda, Akihiro; Hoshino, Junichi; Kondo, Daisuke; Yokoo, Takashi; Kashihara, Naoki; Narita, Ichiei; Suzuki, Yusuke
err分享
err收藏
Treatment of chronic kidney disease in older populations老年慢性肾脏病的治疗
errNATURE REVIEWS NEPHROLOGY
IF39.8
err2024-07-08
err4
PREAI
errKishi, Seiji; Kadoya, Hiroyuki; Kashihara, Naoki
err分享
err收藏
Effectiveness of DialBetesPlus, a self-management support system for diabetic kidney disease: Randomized controlled trial (vol 7, 104 , 2024)
errNPJ DIGITAL MEDICINE
IF15.1
err2024-06-15
err0
errOAAI
errWaki, Kayo; Nara, Mitsuhiko; Enomoto, Syunpei; Mieno, Makiko; Kanda, Eiichiro; Sankoda, Akiko; Kawai, Yuki; Miyake, Kana; Wakui, Hiromichi; Tsurutani, Yuya; Hirawa, Nobuhito; Yamakawa, Tadashi; Komiya, Shiro; Isogawa, Akihiro; Satoh, Shinobu; Minami, Taichi; Iwamoto, Tamio; Takano, Tatsuro; Terauchi, Yasuo; Tamura, Kouichi; Yamauchi, Toshimasa; Nangaku, Masaomi; Kashihara, Naoki; Ohe, Kazuhiko
err分享
err收藏
Kidney outcomes of SGLT2 inhibitors among older patients with diabetic kidney disease in real-world clinical practice: the Japan Chronic Kidney Disease Database Ex
errBMJ OPEN DIABETES RESEARCH & CARE
IF4.1
err2024-05-30
err2
errOAAI
errKitaoka, Kaori; Yano, Yuichiro; Nagasu, Hajime; Kanegae, Hiroshi; Chishima, Noriharu; Akiyama, Hiroki; Tamura, Kouichi; Kashihara, Naoki
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
M
Masayuki Yamamoto
H 指数: 193 · 论文数: 2.1K
M
Marcello Tonelli
H 指数: 162 · 论文数: 998
M
Matthew J. Budoff
H 指数: 160 · 论文数: 2.9K
G
George L. Bakris
H 指数: 147 · 论文数: 1.4K
D
David W. Johnson
H 指数: 134 · 论文数: 2.1K
查看更多